INTERROGATING THE SAFETY AND EFFICACY OF A NOVEL STEAP1 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PROSTATE CANCER.

$1,270,330FY2021Defense Health AgencyDOD

University Of California, Los Angeles

Investigators